BFRG Stock Is Back in the Spotlight
BullFrog AI Holdings (NASDAQ: BFRG) has become one of the most volatile small-cap AI names in the market following a series of extraordinary moves this week.
The stock closed at $0.7647 on September 24, after reaching $1.05 on September 23 and trading as low as $0.6626 on September 24. The September 24 close represented a 19.51% decline, following a 58.33% gain on September 23 and a 21.70% advance on September 22.
The user’s original figure of $0.7139 and +57.25% for the past week is therefore no longer the latest verified figure. Using the September 18 close of $0.4638 and the latest confirmed September 24 close of $0.7647, BFRG had gained approximately 64.9% across those five trading sessions.
For September 25, Google Finance is displaying approximately $0.76 in its latest accessible quote, while the latest completed regular-session price remains $0.7647. The company’s own historical-price page currently shows the September 24 data and does not expose a reliable real-time September 25 last-sale quote, so $0.7647 is the safest confirmed regular-session reference for this publication.
BFRG Stock — Latest Verified Market Snapshot
| Metric | Latest September 25 Data |
|---|---|
| Latest accessible quote | ~$0.76 |
| Latest confirmed regular close | $0.7647 |
| September 24 Change | −19.51% |
| September 23 Change | +58.33% |
| September 22 Change | +21.70% |
| Sept. 18 → Sept. 24 Gain | ~64.9% |
| September 24 High | $0.8424 |
| September 24 Low | $0.6626 |
| September 23 High | $1.05 |
| September 24 Volume | ~5.22M shares |
| Shares Outstanding | 18.54M |
| Market Cap | ~$14.18M |
| 52-Week High | $2.04 |
| 52-Week Low | $0.4251 |
| EPS | −$0.47 |
| Average Volume | ~4.19M |
BullFrog AI’s market capitalization is approximately $14 million, placing it firmly in the nano-cap category.
Stock Info: What BullFrog AI Actually Does
BullFrog AI is an artificial-intelligence and machine-learning company focused on analyzing complex biomedical and healthcare datasets.
Its technology platform is built around three complementary capabilities:
bfPREP™ — biology-aware data harmonization.
bfLEAP® — causal AI analytics and patient-subgroup discovery.
bfARENAS™ — structured and auditable decision-support tools.
The company says its AI outputs are designed to be traceable and human-validated rather than functioning as completely autonomous medical decisions.
BullFrog AI’s technology originated from work developed at the Johns Hopkins University Applied Physics Laboratory, according to its SEC filing.
The company’s latest investor activity has also increased visibility. BullFrog AI participated in the iAccess Alpha Best Ideas Conference on September 15–16 and a Water Tower Research Insights Conference on September 22–23, where CEO Vin Singh participated in investor discussions.
BullFrog AI Investor Relations
Technical Table: BFRG’s Momentum Is Strong — But Extremely Stretched
The most recent technical data show a sharp change in BFRG’s momentum profile following the September 22–24 explosion in volume and price.
| Technical Indicator | Latest Reading | Interpretation |
|---|---|---|
| RSI (14) | 63.46 | Bullish, approaching overbought |
| ATR (14) | ~$0.10 | Extremely high volatility relative to price |
| Relative Volume | 1.20× | Elevated activity |
| Short Float | 0.58% | Low reported short exposure |
| SMA20 Position | +43.82% | Price substantially above 20-day average |
| SMA50 Position | +35.13% | Price substantially above 50-day average |
| SMA200 Position | +8.73% | Above long-term average |
| Weekly Performance | +63.40% | Major momentum shift |
| Monthly Performance | +31.82% | Positive |
| Quarterly Performance | +25.16% | Positive |
| YTD Performance | −13.38% | Still negative for 2026 |
| One-Year Performance | −47.26% | Significant longer-term decline |
The latest technical feed reports an RSI of 63.46, while the stock’s 20-, 50- and 200-day positioning has moved substantially upward after the recent spike.
Key Technical Levels
| Level Type | Price |
|---|---|
| Immediate Support | $0.72–$0.76 |
| Major Support | $0.66–$0.67 |
| Secondary Support | $0.57–$0.60 |
| Major Historical Support | $0.49–$0.50 |
| Immediate Resistance | $0.84–$0.85 |
| Major Resistance | $0.95–$1.00 |
| Breakout Resistance | $1.05 |
| Extended Resistance | $1.20–$1.25 |
| Major Historical Resistance | $1.50+ |
| 52-Week Resistance | $2.04 |
The $0.66–$0.67 area is particularly important because September 24’s intraday low was $0.6626. The $0.84–$0.85 zone corresponds with September 24’s high and the next technical hurdle. The previous session’s $1.05 high is the major breakout reference above the $1 psychological level.
Why BFRG Stock Is Trending Now
1. Extreme Volume Has Changed the Trading Profile
The September 23 session produced approximately 191.7 million shares of volume, compared with typical trading volumes in the tens or hundreds of thousands. September 22 also recorded more than 68 million shares.
That represents an enormous increase in participation and explains why BFRG has moved from a relatively quiet nano-cap stock into a highly active trading name.
2. Insider Buying Arrived Just Before the Explosion
SEC Form 4 filings show CEO Vininder Singh purchased 75,000 shares on September 22 at a weighted-average price of $0.5989. The filing notes purchases ranging from $0.5169 to $0.65.
A separate September 22 Form 4 was filed for CFO Joshua Blacher. Third-party ownership data also report the CFO bought approximately 50,000 shares.
These purchases occurred immediately before BFRG’s explosive September 22–23 trading activity.
3. BullFrog AI Has a Major Commercial Agreement
In March, the company announced a commercial agreement with a top-five global pharmaceutical company by 2025 revenue.
Under the agreement, BullFrog AI’s bfLEAP® platform is being used to identify and prioritize drug targets for major depressive disorder. The company described the agreement as its first commercial contract with such a large pharmaceutical partner.
4. September Investor Meetings Increased Visibility
BullFrog AI’s September investor conference schedule placed management directly in front of potential institutional investors on September 15–16 and September 22–23.
There is no current company press release identifying a new commercial contract after the September 8 investor-conference announcement. BullFrog AI’s official press-release page currently lists that September 8 conference announcement as its latest release.
Bull Case: What Could Keep BFRG Moving Higher?
The bullish scenario starts with the company’s AI platform gaining more commercial customers.
BullFrog AI already has a commercial relationship involving a top-five global pharmaceutical company, giving the company external validation of its technology.
The company also has a relatively large opportunity in pharmaceutical R&D because its platforms are designed to help organize biomedical data, identify drug targets and analyze patient subgroups.
Technically, BFRG has also shifted from a quiet trading pattern into a high-volume momentum structure. A sustained move above $0.84–$0.85, followed by a break of $0.95–$1.00, would put the September 23 high of $1.05 back into focus.
Bear Case: The Risks Behind the 65% Weekly Rally
The biggest risk is that BFRG remains a nano-cap company with very limited revenue.
BullFrog AI’s Q2 2026 filing shows:
| Financial Metric | Q2 2026 |
|---|---|
| Revenue | $215,385 |
| Gross Profit | $106,899 |
| R&D Expense | $339,456 |
| Net Loss | $1.37M |
| EPS | −$0.07 |
For the first six months of 2026, revenue was $215,385, while the net loss totaled approximately $2.96 million.
The company also disclosed approximately $6.92 million in cash and cash equivalents at June 30. More importantly, management stated that its cash position was not sufficient to fund planned operations for at least one year beyond the filing date, creating substantial doubt about the company’s ability to continue as a going concern without additional financing or revenue.
Dilution is another issue. By June 30, BullFrog AI had an ATM agreement under which it could sell up to $20 million of common stock, and it had already received approximately $4.8 million of gross proceeds from 3.95 million shares sold under that facility.
Nasdaq Compliance Adds Another Critical Risk
On August 18, Nasdaq granted BullFrog AI an additional 180-day compliance period ending February 8, 2027 after the company failed to regain compliance with the exchange’s minimum $1 bid-price requirement.
BullFrog AI said that, if it does not cure the issue organically, it intends to consider a reverse stock split before the end of the additional compliance period.
The company had already received shareholder approval for a reverse split of between 1-for-2 and 1-for-15.
This is one of the most important factors investors need to understand about BFRG.
A move back above $1 for at least 10 consecutive business days would satisfy the minimum bid-price condition under the stated Nasdaq process. Failure to regain compliance by February 8, 2027 could subject the securities to delisting, although the company would have appeal rights.
SEC filing on BullFrog AI’s Nasdaq compliance status
Prices to Watch Into the September 25 Session
$0.76: The current reference area following September 24’s close.
$0.84–$0.85: The first important resistance zone. A break above this area would indicate that buyers are reclaiming the upper part of September 24’s range.
$0.95–$1.00: The next major resistance area. The psychological $1 level is especially important because of the Nasdaq minimum-bid-price issue.
$1.05: The September 23 intraday high and the clearest near-term breakout trigger.
$0.66–$0.67: The most important immediate downside support, based on September 24’s low.
$0.57–$0.60: Secondary support and the approximate area surrounding the prices at which the CEO and CFO bought shares on September 22.
$0.49–$0.50: Longer-term support from the pre-breakout trading structure.
BFRG Stock Forecast: Bull, Base and Bear Scenarios
| Scenario | Key Condition | Potential Price Zone |
|---|---|---|
| Bull Scenario | Breaks $1.05 on sustained high volume | $1.20–$1.50 |
| Extended Bull | New commercial contracts + sustained Nasdaq compliance | $1.50–$2.04 |
| Base Scenario | Consolidates between major support and resistance | $0.60–$0.95 |
| Bear Scenario | Breaks below $0.66 | $0.50–$0.60 |
| Severe Bear Case | Breaks below $0.49 | New lows possible |
These are technical scenarios, not analyst price targets. Google Finance currently reports no analyst ratings or price targets for BFRG, so there is no reliable consensus target to cite.
The $1.20–$1.50 upside scenario is based on price-extension levels following the recent breakout rather than a fundamental valuation model.
BFRG Stock: The Numbers Investors Need to Know
| Category | Latest Data |
|---|---|
| Latest confirmed close | $0.7647 |
| Approx. current quote | $0.76 |
| Sept. 18–24 return | ~+64.9% |
| Sept. 24 decline | −19.51% |
| Sept. 23 gain | +58.33% |
| Sept. 22 gain | +21.70% |
| 52-week high | $2.04 |
| 52-week low | $0.4251 |
| RSI | 63.46 |
| ATR | ~$0.10 |
| Shares outstanding | 18.54M |
| Market cap | ~$14.18M |
| Q2 2026 revenue | $215,385 |
| Q2 net loss | $1.37M |
| Six-month 2026 net loss | $2.96M |
| Cash at June 30 | $6.92M |
| Nasdaq compliance deadline | February 8, 2027 |
| Minimum bid requirement | $1.00 |
Bottom Line: BFRG Has Momentum — But the $1 Level Matters
BFRG stock has undergone an extraordinary repricing in just three sessions. The stock moved from a September 21 close of $0.493 to a September 23 intraday high of $1.05, before pulling back to $0.7647 by September 24.
The rally has been accompanied by an extraordinary increase in volume and came around the same time as insider purchases, investor conferences and renewed attention on BullFrog AI’s pharmaceutical-AI business.
But the financial profile remains very different from that of a mature AI company. Revenue is still measured in hundreds of thousands of dollars, the company remains loss-making, and its own SEC filing warns of substantial doubt about its ability to fund operations for at least a year without additional financing or revenue.
Technically, $0.66–$0.67 is the key downside zone, $0.84–$0.85 is the first recovery barrier, and $1.00–$1.05 is the decisive upside test.
The biggest structural issue is the Nasdaq requirement: BullFrog AI has until February 8, 2027 to regain compliance, and the company has already said a reverse split could be considered if the share price does not recover organically.
For September 25, BFRG is therefore a high-volatility, catalyst-driven setup where price action, volume and the $1 threshold are more important than traditional valuation multiples.
BullFrog AI’s commercial-agreement announcement
Disclaimer: This publication is entirely for informational and journalistic purposes and does not constitute formal financial, investment or legal advice. BFRG is a nano-cap biotechnology/AI company with very high share-price volatility, limited revenue, continuing losses, financing requirements and Nasdaq minimum-bid-price compliance risk. The latest confirmed regular-session close is $0.7647 on September 24, 2026; the September 25 market session quote available from public sources was approximately $0.76, and real-time prices can change continuously. Support, resistance and scenario levels are technical reference points rather than guaranteed price targets. The bull, base and bear scenarios are analytical illustrations, not investment recommendations. Always conduct independent due diligence and review the company’s SEC filings before trading.
About The Author
